Should You Be Worried About The Neurocognitive Side Effects Of The New Cholesterol Drugs?

Amgen, Sanofi, and Regeneron Pharmaceuticals Inc. have reported additional information about the cholesterol lowering drugs PCSK9 inhibitors. The studies were broadly consistent, showing the powerful cholesterol-lowering effects. However, both studies also reported a small but significant number of adverse neurocognitive effects in people taking the drugs. Via Forbes. Posted March 30, 2015.

–Alanna McCatty

Alanna M.

Alanna M. is a graduate of Pace University.

Did you find this article helpful?

Notify of
Inline Feedbacks
View all comments

Latest News

Covid-19: Side Effects of Trump’s Treatments

Covid-19: Side Effects of Trump’s Treatments

President Donald Trump announced (via Twitter, of course) what some considered unthinkable, and others considered inevitable — that he had tested positive for Covid-19. Over the weekend, he received various treatments  — supplements like vitamin D, zinc and melatonin, an experimental antibody combination, an antiviral drug and a powerful anti-inflammatory…

Un-Sheltering Tips for Your Health and Immune System

Un-Sheltering Tips for Your Health and Immune System

As we all emerge from our bubbles of limited contact with others, we are walking straight into the double whammy of flu season and COVID-19 germs. Can your body fight off exposure to the flu and COVID? Your immune system feeds off the basics of life — sleep, movement, food…